Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer



[
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
[og_img]
https://www.investing.com/news/press-releases/akesos-penpulimab-receives-nmpa-approval-for-firstline-treatment-of-nasopharyngeal-cancer-93CH-3931034


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img